6 мар. 2024 г. · The new drug, resmetirom, was initially developed as a medication for lowering the levels of unhealthy lipids in the body such as cholesterol.

14 мар. 2024 г. · Today, the U.S. Food and Drug Administration approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic ...

24 мар. 2024 г. · “Rezdiffra is meant for adults with NASH who have well-developed, but not extremely severe scarring in their liver, and it should be used along ...

28 мар. 2024 г. · The drug, resmetirom, has also been shown in clinical trials to reduce scar tissue, or fibrosis, in the liver and to lower cholesterol levels ...

28 мар. 2024 г. · The newly approved medication, Rezdiffra, targets a protein directly in the liver and reduces liver fat, inflammation, and scarring.

8 июл. 2024 г. · A new type of cell therapy to treat patients with liver scarring, or cirrhosis, shows promise of being the first medical treatment for this common and lethal ...

Resmetirom is an orally administered, liver-targeted thyroid hormone receptor (THR)-β selective agonist. THR-β agonism increases hepatic fat metabolism and ...

20 авг. 2024 г. · A new UK clinical trial aims to "supercharge" patients' own immune cells to help their livers recover from severe cirrhosis.

14 мар. 2024 г. · The study found that a drug called HRX215 inhibits the MKK4 protein found in liver cells. That appears to trigger the self-healing function of ...

7 мая 2024 г. · The recently approved treatment, called resmetirom, is the first medication to specifically treat MASH and fibrosis.